Research Article

The Matrix Metaloproteinase-1 Gene Polymorphisms as Risk Factor of Pelvic Organ Prolapse in Balinese Woman

Budhi Prasetio Santoso
Sanglah General Hospital, Indonesia
I Gede Mega Putra
Sanglah Hospital, Indonesia
* Corresponding author
I Wayan Megadhana
Sanglah Hospital, Indonesia
Putu Doster Mahayasa
Sanglah Hospital, Indonesia
Anom Suardika
Sanglah Hospital, Indonesia
I. N. Hariyasa Sanjaya
Sanglah Hospital, Indonesia
DOI icon 10.24018/ejmed.2022.4.5.1439

Read Counter
621

Downloads
443

Citations

Share

Article Sidebar

Submitted 2022-07-18
Published 2022-09-02

Read counter = 621 times

Table of Contents

Article Main Content

Pelvic organ prolapse (POP) is a gynecological problem that can worsen the psychosocial, economic, and sexual function of women and often relapses after surgery. POP is associated with weakness of the pelvic floor supporting structures. Pelvic organ prolapse is associated with a reduced quality of life for millions of women worldwide. The purpose of this study was to determine the role of the MMP-1 rs 1799750 gene polymorphisms as a risk factor for pelvic organ prolapse in Balinese women. This observational case-control study involves 30 patients with pelvic organ prolapse as the case group and 30 patients without pelvic organ prolapse as the control group. The study was conducted at the Integrated Biomedical Laboratory, Faculty of Medicine, Udayana University. Three milliliters of venous blood samples were taken from each patient and DNA examination was performed to determine MMP-1 gene polymorphisms. Risk assessment of the MMP-1 gene polymorphism for pelvic organ prolapse was done by controlling for confounding variables, including age, parity, heavy work, body mass index, menopausal status, and history of hysterectomy, through multivariate logistic regression conditional test. Result from this study is the MMP-1 gene polymorphism increased the risk of pelvic organ prolapse 4.33 times compared to non-prolapsed in Balinese women (OR 4.33, 95%CI 1.20 -15.61, p = 0.020). After controlling for various confounding variables, MMP-1 gene polymorphism still increased the risk of pelvic organ prolapse up to 5.52 times (AOR 5.52, 95%CI 1.352-22.50, p = 0.02). Conclusion from this study is MMP-1 gene polymorphism significantly increases the risk of pelvic organ prolapse in Balinese women.

Keywords: Matrix metalloproteinase-1, pelvic organ prolapse, polymorphism

References

  1. Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007; 369(9566): 1027-1038.
    DOI  |   Google Scholar
  2. Neupane R, Sadeghi Z, Fu R, Hagstrom SA, Moore CK, Daneshgari F. Mutation screen of LOXL1 in patients with female pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2014; 20(6): 316-321.
    DOI  |   Google Scholar
  3. Kerkhof MH, Hendriks L, Brölmann HA. Changes in connective tissue in patients with pelvic organ prolapse--a review of the current literature. Int Urogynecol J Pelvic Floor Dysfunct. 2009; 20(4): 461-474.
    DOI  |   Google Scholar
  4. Smith TA, Poteat TA, Shobeiri SA. Pelvic organ prolapse: an overview. JAAPA. 2014; 27(3): 20-33.
    DOI  |   Google Scholar
  5. Sung VW, Hampton BS. Epidemiology of pelvic floor dysfunction. Obstet Gynecol Clin North Am. 2009; 36(3): 421-443.
    DOI  |   Google Scholar
  6. Bradley CS, Zimmerman MB, Qi Y, Nygaard IE. Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol. 2007; 109(4): 848-854.
    DOI  |   Google Scholar
  7. Brown JS, Waetjen LE, Subak LL, Thom DH, Van den Eeden S, Vittinghoff E. Pelvic organ prolapse surgery in the United States, 1997. Am J Obstet Gynecol. 2002; 186(4): 712-716.
    DOI  |   Google Scholar
  8. Megaputra IG, Manuaba IB, Pranamartha AA, Bhargah A. The role of estrogen receptor α, COL3A1, and fibulin-5 genes polymorphisms as risk factors for pelvic organ prolapse in Balinese women. Gineco Eu Journal. 2018; 14(54): 135–140.
     Google Scholar
  9. Machin SE, Mukhopadhyay S. Pelvic organ prolapse: review of the aetiology, presentation, diagnosis and management. Menopause Int. 2011; 17(4): 132-136.
    DOI  |   Google Scholar
  10. Khadzhieva MB, Kamoeva SV, Ivanova AV, Abilev SK, Salnikova LE. Elastogenesis-related gene polymorphisms and the risk of pelvic organ prolapse development. Genetika. 2015; 51(10): 1191-1198.
    DOI  |   Google Scholar
  11. Quaghebeur J, Petros P, Wyndaele JJ, De Wachter S. Pelvic-floor function, dysfunction, and treatment. Eur J Obstet Gynecol Reprod Biol. 2021; 265: 143-149.
    DOI  |   Google Scholar
  12. Gill EJ, Hurt WG. Pathophysiology of pelvic organ prolapse. Obstet Gynecol Clin North Am. 1998; 25(4): 757-769.
    DOI  |   Google Scholar
  13. Ferrari MM, Rossi G, Biondi ML, Viganò P, Dell'utri C, Meschia M. Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse. Arch Gynecol Obstet. 2012; 285(6): 1581-1586.
    DOI  |   Google Scholar
  14. PW Ming. Regulation of extracelluler matrix remodeling associated with pelvic organ prolapse. J Exp Clin Med. 2010; 2(1): 11-6.
    DOI  |   Google Scholar
  15. Jack GS, Nikolova G, Vilain E, Raz S, Rodríguez LV. Familial transmission of genitovaginal prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2006; 17(5): 498-501.
    DOI  |   Google Scholar
  16. Bortolini MA, Rizk DE. Genetics of pelvic organ prolapse: crossing the bridge between bench and bedside in urogynecologic research. Int Urogynecol J. 2011; 22(10): 1211-1219.
    DOI  |   Google Scholar
  17. Skorupski P, Jankiewicz K, Miotła P, Marczak M, Kulik-Rechberger B, Rechberger T. The polymorphisms of the MMP-1 and the MMP-3 genes and the risk of pelvic organ prolapse. Int Urogynecol J. 2013; 24(6): 1033-1038.
    DOI  |   Google Scholar
  18. Jeon MJ, Chung SM, Choi JR, Jung HJ, Kim SK, Bai SW. The relationship between COL3A1 exon 31 polymorphism and pelvic organ prolapse. J Urol. 2009; 181(3): 1213-1216.
    DOI  |   Google Scholar
  19. Pardo A, Selman M. MMP-1: the elder of the family. Int. J. Biochem. Cell Biol. 2005; 37(2): 283-288.
    DOI  |   Google Scholar
  20. Huang XY, Han LY, Huang XD, Guan CH, Mao XL, Ye ZS. Association of Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Variants with Ischemic Stroke and Its Subtype. J Stroke Cerebrovasc Dis. 2017; 26(2): 368-375.
    DOI  |   Google Scholar
  21. Swift S, Woodman P, O'Boyle A, Kahn M, Valley M, Bland D, et al. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005; 192(3): 795-806.
    DOI  |   Google Scholar
  22. Horst W, do Valle JB, Silva JC, Gascho CLL. Pelvic organ prolapse: prevalence and risk factors in a Brazilian population. Int Urogynecol J. 2017; 28(8): 1165-1170.
     Google Scholar
  23. Rahmatyah R, Hardiyanto G, Susanti D. Correlation between pelvic organ prolapse symptoms and age of menopause. Majalah obstet. ginekol. Indones. 2017;25(1):30–32.
    DOI  |   Google Scholar
  24. Huang L, Zhao Z, Wen J, Ling W, Miao Y, Wu J. Cellular senescence: A pathogenic mechanism of pelvic organ prolapse (Review). Mol Med Rep. 2020; 22(3): 2155-2162.
    DOI  |   Google Scholar
  25. Aytan H, Ertunç D, Tok EC, Yaşa O, Nazik H. Prevalence of pelvic organ prolapse and related factors in a general female population. Turk J Obstet Gynecol. 2014; 11(3): 176-180.
    DOI  |   Google Scholar
  26. Quiroz LH, Muñoz A, Shippey SH, Gutman RE, Handa VL. Vaginal parity and pelvic organ prolapse. J Reprod Med. 2010; 55(3-4): 93-98.
     Google Scholar
  27. Whitcomb EL, Lukacz ES, Lawrence JM, Nager CW, Luber KM. Prevalence and degree of bother from pelvic floor disorders in obese women. Int Urogynecol J Pelvic Floor Dysfunct. 2009; 20(3): 289-294.
    DOI  |   Google Scholar
  28. Ramalingam K, Monga A. Obesity and pelvic floor dysfunction. Best Pract Res Clin Obstet Gynaecol. 2015; 29(4): 541-547.
    DOI  |   Google Scholar
  29. Forner LB, Beckman EM, Smith MD. Symptoms of pelvic organ prolapse in women who lift heavy weights for exercise: a cross-sectional survey. Int Urogynecol J. 2020; 31(8): 1551-1558.
    DOI  |   Google Scholar
  30. Weintraub AY, Glinter H, Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int Braz J Urol. 2020; 46(1): 5-14.
    DOI  |   Google Scholar
  31. Zhou L, Shangguan AJ, Kujawa SA, Bochenska K, Zhang L, Zhao H. et al. Estrogen and pelvic organ prolapse. J Mol Genet Med. 2016; 10(2): 221.
    DOI  |   Google Scholar
  32. Sze EH, Hobbs G. A prospective cohort study of pelvic support changes among nulliparous, multiparous, and pre- and post-menopausal women. Eur J Obstet Gynecol Reprod Biol. 2012; 160(2): 232-235.
    DOI  |   Google Scholar
  33. Forsgren C, Lundholm C, Johansson AL, Cnattingius S, Zetterström J, Altman D. Vaginal hysterectomy and risk of pelvic organ prolapse and stress urinary incontinence surgery. Int Urogynecol J. 2012; 23(1): 43-48.
    DOI  |   Google Scholar
  34. Horst W, do Valle JB, Silva JC, Gascho CLL. Pelvic organ prolapse: prevalence and risk factors in a Brazilian population. Int Urogynecol J. 2017; 28(8): 1165-1170.
    DOI  |   Google Scholar


Most read articles by the same author(s)

1 2 > >>